Notably, both TAE-684 and HG7-92-01 were more potent than the previously reported Flt3 inhibitor, tandutinib [18,19], which yielded IC50 values ranging from 232 to 502 nM in the Flt3-ITD+ AML cell lines. The gene discussed is FLT3; the disease is acute myeloid leukemia.